Empowered By Us welcomes the publication of the Proposal for a Regulation establishing the European Biotech Act. The structured framework and focus on strengthening health biotechnology capacity in the Union are important steps toward enhancing competitiveness and resilience. At the stage of Commission adoption, we offer three targeted observations to strengthen implementation effectiveness. 1.
EBU
Empowered By Us
Other · Netherlands · EU Transparency Register 246166594802-94
2
positions filed
in the 326 files tracked
1
legislative file
of 326 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track Empowered in PolicySpeak: request access →
Work at Empowered By Us? so we know who speaks for it.
Their record over time
Empowered By Us filed 2 positions between 5 Jun 2025 and 11 Feb 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 1 time.
2025 · 1 filed2026 · 1 filed
What they argued
Empowered By Us is an independent, patient-led initiative focused on equitable health innovation, rare disease policy, and strategic patient involvement. We welcome the opportunity to contribute to the development of the EU Biotech Act. The Biotech Act must not only support scientific excellence. It must also foster innovation that is accessible, societally meaningful, and system-ready.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from Empowered By Us’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.